Ascendis Pharma A/S
Ascendis Pharma A/S (ASND) Company Profile & Overview
Explore Ascendis Pharma A/S’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.
Ascendis Pharma A/S (ASND) Company Profile & Overview
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult hypoparathyroidism; and TransCon CNP for pediatric achondroplasia. In addition, the company develops TransCon toll like receptors 7/8 agonist for intratumoral delivery; and TransCon IL-2 ß/g for systemic delivery. The company was incorporated in 2006 and is headquartered in Hellerup, Denmark.